Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
Original Article
M.E. Wechsler, P. Nair, B. Terrier, B. Walz, A. Bourdin, D.R. Jayne, D.J. Jackson, F. Roufosse, L.B. Sjö, Y. Fan, M. Jison, C. McCrae, S. Necander, A. Shavit, C. Walton, and P.A. Merkel
N Engl J Med 2024;390:911-921
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.